Magnesium Blood Glucose Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Thus, this review aims to integrate advances in magnesium physiology with contemporary clinical and nutritional evidence, providing a consolidated strategy for understanding the causes, manifestations, diagnosis, and management of hypomagnesemia. [Papagiannidou Anastasia (2026); evidence level 3]
• Finally, we also cover practical laboratory assessment and evidence-informed repletion strategies. [Papagiannidou Anastasia (2026); evidence level 3]
• Following the successful reduction in deficiency-related disorders, from the 1950s onward, the focus in affluent societies increasingly shifted toward chronic non-communicable diseases associated with modern lifestyles. [Háber Andor Zsolt (2026); evidence level 4]
• In an effort to mitigate the risk of such diseases, the concept of functional foods emerged. [Háber Andor Zsolt (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For magnesium blood glucose meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Papagiannidou Anastasia (2026). Hypomagnesemia: A Clinical and Nutritional Update. DOI: 10.1007/s13668-026-00745-5. PMCID: PMC13009017. PMID: 41872423. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/
• Háber Andor Zsolt (2026). Evaluating Large Language Models for Food Supplement Development: A Case Study in Glycemic Control. DOI: 10.3390/nu18081228. PMCID: PMC13119470. PMID: 42075041. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13119470/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.